GRP
TVTX icon

Global Retirement Partners’s Travere Therapeutics TVTX Stock Holding History

Global Retirement Partners’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.74K Buy
+101
New +$4.48K ﹤0.01% 3652
2025
Q4 		$3.25K Buy
+85
New +$2.76K ﹤0.01% 3573
2024
Q2 		– Sell
-19
Closed -$146 – 3643
2024
Q1 		$146 Hold
19
– – ﹤0.01% 3280
2023
Q4 		$169 Buy
+19
New +$138 ﹤0.01% 3241

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Global Retirement Partners's TVTX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 101 shares worth $5.74K. The stake represents ﹤0.01% of the portfolio and ranks #3652 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in TVTX as recently as Q4 2025.

Global Retirement Partners first reported a position in TVTX in Q4 2023 and has held it in 4 quarters since. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Global Retirement Partners held 101 shares of Travere Therapeutics worth $5.74K as of Q2 2026.
  • Travere Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Travere Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3652 holding.
  • Global Retirement Partners first reported a position in Travere Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • 321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.